AB
Arix Bioscience
Venture CapitalActiveArix Bioscience is a healthcare and life science company.
19
Investments
3
Exits
$450M
AUM
15.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Arix Bioscience.
Investment Thesis & Strategy
Arix Bioscience invests in various stages of healthcare and life science companies, seeking to build and develop innovative businesses in the biotech and healthcare sectors.
Investment Activity
Deals per year over the last 6 years
4
20162
20170
20181
20191
20202
2021Portfolio Companies
Selected investments from their portfolio of 19 companies
K
Kyverna Therapeutics
Biotech · Series A, 2021
E
ELIXIRGEN Therapeutics
Biotech · Series A, 2021
V
VelosBio
Biotech · Series B, 2020
I
ImmuNext
Biotech · Series A, 2019
B
Biohaven Pharmaceutical
Biotech · Growth, 2017
D
Depomed
Biotech · Growth, 2017
I
Iterum Therapeutics
Biotech · Series A, 2016
H
Harpoon Therapeutics
Biotech · Series A, 2016
L
LogicBio Therapeutics
Biotech · Series A, 2016
A
Autifony Therapeutics
Biotech · Series A, 2016
Notable Exits
CompanyTypeYearValue / Acquirer
VelosBioAcquisition2020$2.75B
Harpoon TherapeuticsIPO2019$100M
Autolus TherapeuticsIPO2018$150M
Frequently Asked Questions
Arix Bioscience focuses on Series A, Series B, Series C+ stage investments.